Drugs / microbiota transplant therapy
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06481852 | Oct 2024 → Oct 2026 expected | pulmonary arterial hypertension | University of Minnesota | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | microbiota transplant therapy | “This pilot clinical trial will evaluate the initial safety, feasibility, and pharmacokinetics of microbiota transplant therapy (MTT) with antibiotic pre-conditioning and fiber...” NCT06481852 ↗ |
| Known as | MTT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06481852 ↗ |